Copyright © 2024 MarketWatch, Inc. All rights reserved.

TD Cowen analyst Charles Rhyee maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $85.00. The company’s shares closed yesterday at $61.61.

CVS Health is well-positioned to maintain its relevance and continue thriving in this competitive landscape. This text provides general information. Statista assumes no liability for the ...

The American retail giant is reportedly testing a new technology that allows employees to unlock cases without manually using ...

CVS said that it is looking for additional partners to join the new service, potentially including support for smoking cessation and substance abuse, care management solutions, medicine ...

On Feb. 2, 2023, the chief executive of Chicago-based Oak Street Health Inc. e-mailed senior executives that the company would be acquired by CVS Health Corp. One of the Oak Street executives briefed ...

Cantor Fitzgerald analyst Sarah James maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $62.00. The company’s shares closed yesterday at $61.61.

LOS ANGELES — The unions representing more than 7,000 CVS workers in Southern California have reached a tentative agreement on a contract after workers went on strike over the weekend demanding ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Over the weekend, unionized pharmacy workers at seven CVS pharmacies in Southern California went on strike to protest the company's Unfair Labor Practices (ULPs). In August, UFCW Locals in ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Reviews ethics statement ...